Tilray Brands Inc

NASDAQ: TLRY
$1.54
-$0.23 (-13.0%)
Closing Price on November 6, 2024

TLRY Articles

With evolving societal and regulatory landscapes, the upside potential of cannabis as a new investment strategy has emerged. Investors can use a number of ETFs to invest in the future of cannabis.
Tilray shares dipped on Monday despite its announcement that it would be branching out and supporting two new clinical studies.
It seems that cannabis stocks such as Canopy Growth and Tilray have become more normalized in the United States and legislation is on the way.
Tilray shares got a boost after the cannabis firm released its most recent quarterly results after the markets closed on Monday.
Tilray shares jumped on Thursday after the firm made a couple updates to its business. First, Tilray announced that it has made a few additions to its global senior leadership team. Separately, the...
Tilray shares are back under $100, and a routine IPO lock-up expiration has removed almost 10% of the value of its shares in just one day.
The world of legalized marijuana and cannabis sales is expected to keep growing, and a new 2019 forecast projects even stronger growth.
Investment in cannabis-related companies rose nearly fourfold year over year in 2018. Can 2019 maintain that pace?
Initial public offerings and significant investment by established firms raised the valuations of several companies in the marijuana-related sector. Here are the 10 largest firms at the end of 2018.
Budweiser brewer AB InBev and Canadian marijuana firm Tilray announced a $100 million joint research effort that could result in new marijuana-laced adult beverages. How can it cost so much to...
A total of 190 companies came public in 2018 on U.S. exchanges and raised a total of more than $46 billion in fresh capital. The year is ending on a down note and the question is the effect of the...
Tilray shares made a solid gain on Tuesday after the company announced that it entered a global agreement to collaborate with Sandoz, a subsidiary of Novartis.
24/7 Wall St. has identified 10 highly speculative stocks that have been received Wall Street analyst calls in the past 10 days in which the analysts have projected upside of 50% to 300%.
Tilray has done what many companies do after a very large stock move. It is raising cash.
Tilray shares got a little higher on Wednesday after the company announced that it had entered into a supply agreement with 7ACRES, a subsidiary of Supreme Cannabis.